PIK3CA and malignant colon neoplasm: The statistics have shown that the mutation rates of PIK3CA and PTEN in CRCs are ∼12% and ∼6%, respectively; mutations of PIK3CA are common in exon 9 and exon 20, and mainly occur in colon-cancer patients [77–79].